Arousal Support
Apomorphine acts on dopamine pathways in the central nervous system that may influence sexual arousal.
Compounded dissolvable oxytocin and apomorphine with licensed provider oversight and an individualized sexual wellness plan.
Starting FromPricing shown for information only. Your plan is confirmed after your free consultation.
Start Your JourneyPrescription products require an online consultation with a licensed healthcare provider who will determine whether treatment is appropriate.
Oxytocin/Apomorphine Troches are a compounded prescription treatment combining oxytocin, a hormone involved in reproductive and social signaling, with apomorphine, a dopamine receptor agonist. The combination may be considered in select sexual wellness treatment plans, but its use for sexual desire, arousal, or intimacy is not FDA-approved.
Apomorphine acts on dopamine pathways in the central nervous system that may influence sexual arousal.
Oxytocin is involved in reproductive and social signaling and has been studied for potential roles in sexual response and intimacy.
The troche is designed to dissolve in the mouth as directed by your healthcare provider.
Treatment is based on your symptoms, medications, cardiovascular health, medical history, and individual clinical needs.
Changes in sexual desire, arousal, or satisfaction can have hormonal, neurological, cardiovascular, psychological, medication-related, and other causes that should be evaluated before treatment.
Persistent difficulty becoming or remaining sexually aroused may warrant medical evaluation.
Reduced sexual interest can have multiple causes that should be considered before treatment.
A provider may evaluate whether a customized treatment approach is appropriate.
Apomorphine has important blood pressure, sedation, and medication-interaction risks that require careful review.
Sexual health concerns can have many possible causes. A licensed healthcare provider will evaluate your health history, medications, cardiovascular health, symptoms, and individual needs before recommending treatment.
Apomorphine stimulates dopamine receptors in the central nervous system and can affect neurological pathways involved in arousal and sexual response. Oxytocin acts on oxytocin receptors involved in reproductive, hormonal, and neural signaling. The safety and effectiveness of combining oxytocin and apomorphine in a troche specifically for sexual wellness have not been established through FDA approval.
Oxytocin/Apomorphine Troches may cause side effects, and individual experiences can vary.
Your provider will review your medications, cardiovascular history, pregnancy status when relevant, neurological health, and other potential risks before treatment.
Share your medical history, current symptoms, medications, cardiovascular history, sexual health concerns, and treatment goals through our secure online assessment.
Meet remotely with a licensed healthcare provider who will review your information and determine whether Oxytocin/Apomorphine Troches may be appropriate.
If treatment is prescribed, your care plan and medication will be coordinated through the appropriate licensed pharmacy, with administration instructions and ongoing provider oversight.
Discover other provider-guided treatments available through Premier Hormone Health.
Personalized hormone therapy guided by experienced providers.
Physician-guided plans for sustainable body composition improvement.
Targeted support for recovery, injury repair, and skin and hair health.
Oxytocin/Apomorphine Troches are dissolvable prescription formulations combining oxytocin with apomorphine. The combination may be considered as part of an individualized sexual wellness treatment plan but is not FDA-approved for sexual dysfunction.
Apomorphine stimulates dopamine receptors in the brain and may affect pathways involved in arousal. FDA-approved apomorphine products are indicated for motor fluctuations associated with Parkinson’s disease, so its use for sexual wellness is off-label.
Oxytocin is a naturally occurring hormone involved in reproductive, social, and neural signaling. Its use for sexual desire, arousal, intimacy, or satisfaction is not FDA-approved, and evidence for these uses remains limited.
A licensed healthcare provider may evaluate you through telehealth and determine whether treatment is clinically appropriate. If prescribed, the medication should be dispensed through an appropriately licensed pharmacy.
No. The combined Oxytocin/Apomorphine Troche is not an FDA-approved drug product. FDA-approved oxytocin products are used for specific obstetric indications, while FDA-approved apomorphine products are used for Parkinson’s disease. Approval of those individual medications does not extend to this combination or its use for sexual wellness.